title: Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris.
authors: Emma E
authors: EE
authors: Craythorne
authors: Ghulam
authors: G
authors: Mufti
authors: Anthony W
authors: AW
authors: DuVivier
mesh_terms: D000082:Acetaminophen / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D002744:Chlorpheniramine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000082:Acetaminophen; D002744:Chlorpheniramine; D000069283:Rituximab; D011241:Prednisone; D006854:Hydrocortisone